Navigation Links
Viropro Initiates Interim Debt Financing of Up to $500,000
Date:8/25/2014

SAN JOSE, Calif., Aug. 25, 2014 /PRNewswire/ -- Viropro, Inc. today announced that it has entered into a definitive agreement with Spring Hill Bioventures outlining the terms through which the company will raise up to $500,000 in convertible debt.  Simultaneously, Spring Hill has closed on an initial commitment of $200,000.

The proceeds of the financing will be used for the preparation of audited financial statements, the implementation of the company's strategic plans and for general corporate purposes.

"These new funds will allow us to begin the process of turning Viropro around and for bringing the company into compliance with reporting requirements," said Dr. Joseph Vallner, Acting CEO.  "While many challenges remain ahead, we are confident that we will be able to implement our aggressive plans for building the company."

At or prior to maturity the note may be converted by the note holder, or prepaid by Viropro with notice to allow the note holder to convert.  If not converted or prepaid within 12 months of issue, the notes will automatically convert into common stock of Viropro at a conversion rate of $.01 per share. 

If the full value of the notes are purchased, note holders will be granted warrants entitling them to purchase from Viropro up to 7,000,000 shares of common stock at a price of $.06 per share.  The notes carry an interest rate of 12% per year.

"We are delighted with the progress that Viropro has made since the new management team was put into place, and we are excited about the future prospects of the company," said Bruce Cohen, Chairman of Viropro's Board of Directors.  "This commitment by our largest shareholder reflects confidence in our new direction."

Under the terms of the agreement with Spring Hill additional notes may be sold
'/>"/>

SOURCE Viropro, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
3. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
6. MAQUET Initiates Class I Recall of the FLOW-i Anesthesia System
7. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
10. Empire Asset Management Co. Initiates Coverage on Transcept Pharmaceuticals Inc., (NASDAQ: TSPT)
11. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014  Sanguine Biosciences – a biotechnology ... study recruitment – will use its proprietary mobile ... Pfizer Inc. find and recruit people diagnosed with ... members to participate in voluntary research, which will ... and hopefully aid in informing the development of ...
(Date:11/18/2014)... Nov. 18, 2014  TransCelerate BioPharma Inc. ... recent manuscript on Risk-Based Monitoring (RBM), " ... Control Measure in Clinical Trials ," in ... & Regulatory Science  (TIRS) journal. Developed by ... Medidata, the manuscript examines the value of ...
(Date:11/18/2014)... 2014 Pressure BioSciences, Inc. (OTCQB: PBIO) ... of its first two Barozyme HT-48 high throughput ... One system was placed in the laboratory of ... while the other was placed in the laboratory ... the Company believes the new systems will deliver ...
Breaking Medicine Technology:Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5
... SALT LAKE CITY, Nov. 17 ("WorldHeart"; Nasdaq: ... that it has finalized assignment and exclusive license agreements ... Mellon University (CMU), Pittsburgh, Pennsylvania for its next-generation minimally ... to provide partial cardiac support between 2-4 liters per ...
... Mich., Nov. 17 Bonovo Orthopedics, Inc., a leading ... government approval to market Pioneer,s full portfolio of spinal ... Chinese Orthopaedic Association annual meeting - the largest and ... and is planning a comprehensive rollout of Pioneer,s Quantum® ...
Cached Medicine Technology:WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump 2WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump 3Pioneer(R) Surgical Technology, Inc. and Bonovo(R) Orthopedics, Inc. Establish Foothold in Fastest Growing Spine Market in the World 2
(Date:11/18/2014)... Dennis Thompson HealthDay ... -- Daily low-dose aspirin therapy may not have significant ... The study, which involved more than 14,000 Japanese ... in heart-related deaths or non-fatal heart attacks and strokes ... "It indicates that primary prevention with daily ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... Heart attack and stroke patients can safely take aspirin combined ... blood-thinning combination won,t increase a patient,s risk of early death, ... meeting of the American Heart Association in Chicago. The report ... . Analysis of data from more than a dozen ...
(Date:11/18/2014)... MONDAY, Nov. 17, 2014 (HealthDay News) -- Until recently, insect-transmitted ... America, but it has made its way to the United ... fatal illness is typically transmitted via the bite of the ... night. And now a new study suggests that common bedbugs ... bedbug can acquire and transmit the parasite. Our next step ...
(Date:11/17/2014)... Los Angeles, CA (PRWEB) November 17, 2014 ... revealed that thousands of patients throughout the country are ... feeling better than ever before. This is because the ... hormone therapy to their already impressive collection of prescription ... , Those who have incorporated Diet Doc’s best ...
(Date:11/17/2014)... World Food Processing announced today that ... American Farmer airing via RFD-TV 2nd QTR 2015. American ... RFD-TV. , World Food Processing is a sustainable solution ... unique system provides a secure system, supplying non-GMO and ... segment will educate viewers about World Food Processing’s unparalleled ...
Breaking Medicine News(10 mins):Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:American Farmer to Feature World Food Processing in 2015 Series 2
... (Washington) - The American College of Physicians (ACP) today ... understands the serious financial constraints on the federal budget ... funding for discretionary programs that do not achieve sufficient ... a path towards reversing an unprecedented shortage of primary ...
... By Alan Mozes HealthDay Reporter , TUESDAY, ... overuse may be more common than thought among high ... sports, a new study finds. "The risk is ... are constantly trying to perfect their performance, and sometimes ...
... Agarwal, MD, the chief of surgical critical care at ... medicine at Boston University School of Medicine (BUSM), has ... (NTI) to identify optimal treatment methods for acute lung ... involves seven level one trauma centers and includes one ...
... Feb. 15, 2011 Breast-cancer patient Kristin Wiginton is ... with high-beam radiation using the Accuray CyberKnife System, which offers ... a shorter treatment period. Dr. Wiginton is among ... first of its kind in the Southwest investigating use ...
... that works in the "real world" may more ... based only on findings in clinical research settings, ... Heart Association,s cardiovascular disease prevention guidelines for women., ... have been primarily based on findings observed in ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... knee are robbing millions of older Americans of an average ... be feeling healthy and free of chronic pain, new research ... obese and/or have osteoarthritis of the knee, an often painful ...
Cached Medicine News:Health News:House leaders told some cuts in budget resolution could increase shortage of primary care physicians 2Health News:Stress Fractures Hitting High School Athletes 2Health News:Stress Fractures Hitting High School Athletes 3Health News:UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife 2Health News:UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife 3Health News:Updated heart disease prevention guidelines for women focus more on 'real-world' recommendations 2Health News:Updated heart disease prevention guidelines for women focus more on 'real-world' recommendations 3Health News:Obesity, Bum Knees Robbing Seniors of Good Years: Study 2Health News:Obesity, Bum Knees Robbing Seniors of Good Years: Study 3
... feature 20 bipolar-spaced electrodes along a ... of mapping resolution in atrial fibrillation ... 20-pole catheter enables more accurate pinpointing ... 10-pole catheter systems. The result: greater ...
... Steerable Introducer helps physicians to ... or left atrium. With precise ... and radiopaque tip marker, the ... agility and stability needed for ...
The Microny pacemakers are among the smallest devices in the world. The Microny II SR+ pacemaker is the world's smallest, single-chamber rate-responsive pulse generator. The Microny pacemakers featur...
... Identity pacemaker family, which includes ... provides clinicians with the most ... the revolutionary AF Suppression™ algorithm, ... commercially approved algorithm designed to ...
Medicine Products: